Study Title: A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Gourdin, Theodore, at gourdith@musc.edu.Study Coordinator, Boggan, Holly, at bogganhl@musc.edu, or please call +1 843-792-8068.Trial opened at the following institutions: Medical University of South Carolina